SEQENS Revenue

Pharmaceutical Manufacturing • Écully, Auvergne-Rhône-Alpes, France • 1001-2000 Employees

SEQENS revenue & valuation

Annual revenue	$1,351,100,000
Revenue per employee	$1,038,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$4,323,500,000
Total funding	No funding

Key Contact at SEQENS

Ilan Avni

CEO Wavelength Pharmaceuticals Ltd., General Manager SEQENS Israel

Mobile @seqens.com

Company overview

Headquarters	21, Chemin de la Sauvegarde, Écully, Auvergne-Rhône-Alpes 69130, FR
Phone number	+33426991800
Website	seqens.com
NAICS	3254
SIC	283
Keywords	Cosmetics, R&D, Generics, Specialty Ingredients, Cdmo, Personnal Care, Pharmaceutical Synthesis, Custom Specialties, Crdo, Innovative Pharmaceuticals
Founded	2003
Employees	1001-2000
Socials

SEQENS Email Formats

SEQENS uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@seqens.com), used 75.2% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@seqens.com	75.2%
{first initial}.{last name}	j.doe@seqens.com	24.8%

About SEQENS

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Employees by Management Level

Total employees: 1001-2000

Seniority

Employees

Entry

Manager

Head

Employees by Department

SEQENS has 531 employees across 14 departments.

Departments

Number of employees

Funding Data

Explore SEQENS's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2016-07-22	11	N/A

Funding Insights

Number of funding rounds

SEQENS Tech Stack

Discover the technologies and tools that power SEQENS's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Polyfill

JavaScript libraries

Gravity Forms

Form builders

WP Rocket

Caching

PWA

Miscellaneous

Goober

JavaScript libraries

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HubSpot Analytics

Analytics

Apple iCloud Mail

Webmail

PHP

Programming languages

Frequently asked questions

SEQENS is located in Écully, Auvergne-Rhône-Alpes, FR.

You can reach SEQENS at +33426991800.

SEQENS generates an estimated annual revenue of $1,351,064,000. This revenue figure reflects the company's market position and business performance in its industry.

SEQENS has an estimated valuation of $4,323,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

SEQENS was founded in 2003, making it 23 years old. The company has established itself as a significant player in its industry over this time.

SEQENS has approximately 1001-2000 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at SEQENS

Ilan Avni

CEO Wavelength Pharmaceuticals Ltd., General Manager SEQENS Israel

Mobile @seqens.com

4.8

40,000 users